Sort
48,018 grants matching “immunotherapy”
Immunotherapy For Latex Rubber Allergy
$408,750Johns Hopkins University · R01 · FY2005 · AI
Immunological Monitoring of Heart Allograft Recipients
$408,750Columbia University Health Sciences · R01 · FY2004 · AI
Immunological Monitoring of Heart Allograft Recipients
$408,750Columbia University Health Sciences · R01 · FY2003 · AI
Immunotherapy For Latex Rubber Allergy
$408,750Johns Hopkins University · R01 · FY2003 · AI
Immunotherapy For Latex Rubber Allergy
$408,750Johns Hopkins University · R01 · FY2004 · AI
Targeting eIF4A1 in drug-resistant breast cancer stem-like cells
$408,726Dayanidhi Raman · University Of Toledo Health Sci Campus · R01 · FY2022 · CA
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
$408,718Guangyong Peng · Washington University · R01 · FY2023 · CA
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$408,703Edgar G. Engleman · Stanford University · P01 · FY2024 · CA
IL13Ra2 targeted T-cell therapy for glioma
$408,625Irina V Balyasnikova · University Of Chicago · R21 · FY2014 · NS
CLINICAL IMAGING AND RADIATION DOSIMETRY
$408,610James R Bading · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA
A Novel ULK1 Pathway as a New Therapeutic Target in Melanoma
$408,596Diana Nora Vaz Saleiro · Northwestern University At Chicago · R21 · FY2020 · CA
Immunization to Block the Effects of Nicotine
$408,596Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2011 · DA
Protective Host Immunity Against Pulmonary Cryptococcosis
$408,541Floyd L. Wormley · University Of Texas San Antonio · R01 · FY2017 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$408,517William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2015 · AI
Targeting diacylglycerol kinases in glioblastoma
$408,495Benjamin W. Purow · University Of Virginia · R01 · FY2015 · CA
Targeting diacylglycerol kinases in glioblastoma
$408,495Benjamin W. Purow · University Of Virginia · R01 · FY2016 · CA
Targeting diacylglycerol kinases in glioblastoma
$408,495Benjamin W. Purow · University Of Virginia · R01 · FY2014 · CA
Targeting diacylglycerol kinases in glioblastoma
$408,495Benjamin W. Purow · University Of Virginia · R01 · FY2017 · CA
Regulation of CD8+T cells by Zbtb42
$408,469Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2024 · CA
PRE-CLINICAL ANIMAL TESTING
$408,465University Of Cincinnati · U19 · FY2000 · DA
ANTIBODY CHARACTERIZATION
$408,465University Of Cincinnati · U19 · FY2000 · DA
CHALLENGE STUDY FOR ANTI-COCAINE ANTIBODIES
$408,465University Of Cincinnati · U19 · FY2000 · DA
PHASE 1 SAFETY TRIALS--HUMAN MONOCLONAL ANTI-COCAINE ANTIBODY
$408,465University Of Cincinnati · U19 · FY2000 · DA
BOSTON AIDS MALIGNANCY CONSORTIUM
$408,452Massachusetts General Hospital · U01 · FY2002 · CA
Preventing tumor relapse with biomaterial-supported lymphocyte implants
$408,426Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA